Corpus ID: 45003329

Late diagnosis of HIV infection in asymptomatic patients.

  title={Late diagnosis of HIV infection in asymptomatic patients.},
  author={Mariana A Kundro and Sofie Rosanne Terwel and Javier J. Toibaro and Guillermo Alberto Viloria and Marcelo Losso},
  volume={76 5},
Recent findings from the START Trial provided evidence that early initiation of antiretroviral treatment should be implemented as the global standard of care. However, a large proportion of patients are still being diagnosed in late stages. Our objective was to evaluate the temporal trend in the CD4+ cell count at diagnosis during a 13 year period and the factors associated with late HIV diagnosis in asymptomatic individuals tested in the Centre for Prevention, Counselling and Diagnosis of our… Expand
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region
The prevalence of HIV/EBV coinfection was lower than that observed in other studies, and social vulnerability and promiscuous sexual behavior were associated risk factors. Expand
HIV Testing Uptake and Late Diagnosis among Urban Population of Ethiopia: A Multilevel Modeling Approach
Ethiopia was behind the global target for HIV testing uptake and late diagnosis, and this was significantly higher among adult males, and the HIV testing offer and early diagnosis strategy need to focus on addressing geographically highly affected regions, and male and young adolescent age groups. Expand
HIV prevention strategies and risk of infection: a model-based analysis
RDT-based pre-screening of potential sex partners prior to unprotected sexual contacts substantially reduces HIV transmission risk and combination of different prevention strategies is advisable for high-risk groups. Expand
The role of brain biopsy in the clinical management of HIV‐related focal brain lesions
The clinical outcomes of patients with FBL, the proportion of diagnoses confirmed by brain biopsies and their aetiologies, and theportion of patients in whom the biopsy motivated a change in therapeutic management are described are described. Expand


Late Presentation into Care of HIV Disease and Its Associated Factors in Asia: Results of TAHOD.
The identified risk factors associated with late presentation should be utilized in formulating targeted public health intervention to improve earlier entry into HIV care. Expand
Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011
Older people, people diagnosed in Central and Southern Italy, non nationals, and persons who acquired the infection through injecting drug use or heterosexual contact showed a higher risk of being diagnosed late. Expand
Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001-2009
Late presentation of HIV is still too frequent in all transmission groups in spite of a strong commitment with HIV prevention in Barcelona (Spain), and it is necessary to develop interventions that increase HIV testing and facilitate earlier entry into HIV care. Expand
Impact of Late Presentation on the Risk of Death Among HIV-Infected People in France (2003–2009)
LP with HIV infection is still very frequent in France and is associated with higher mortality, even among patients with only moderate immunodeficiency, and encouraging early testing and access to care is still urgently needed. Expand
Prevalence and factors associated with late HIV diagnosis
It is suggested that late HIV diagnosis is common in Liuzhou city, and it is essential to promote appropriate strategies to detect HIV infections earlier, and strategies that require HIV/AIDS patients to notify their spouse/sexual‐partners about their HIV‐positive results within one month and start provider‐initiated HIV testing and counseling in medical facilities are beneficial to earlier HIV diagnosis. Expand
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
The initiation of antiretroviral therapy in HIV-positive adults with a CD4+ count of more than 500 cells per cubic millimeter provided net benefits over starting such therapy in patients after the CD4+, but the risks of unscheduled hospital admissions were similar in the two groups. Expand
Trends on epidemiological, virological, and clinical features among newly diagnosed HIV‐1 persons in Northwest Spain over the last 10 years
The need to facilitate the access for HIV testing to reduce the rate of late HIV diagnosis, improve the clinical outcome and prevent HIV transmission is supported. Expand
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.
A comprehensive and exhaustive search strategy was formulated in an attempt to identify all relevant studies regardless of language or publication status to assess the evidence for the optimal time to initiate ART in treatment-naive, asymptomatic, HIV- infected adults. Expand
Frequency and correlates of late presentation for HIV infection in France: older adults are a risk group – results from the ANRS-VESPA2 Study, France
Promotion of HIV testing should be renewed to target each subgroup at risk while paying a particular attention to middle-aged or older adults whose attitudes and beliefs towards HIV/AIDS might prevent them from seeking testing. Expand
The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period
The sustained high cost for late presenters has implications for recent recommendations for wider routine HIV testing and the earlier initiation of cART, and may produce both direct and indirect cost savings in the longer term. Expand